Kiniksa Pharmaceuticals, Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| HARBOR CAPITAL ADVISORS, INC. | 10/29/2024 | 97,543 | $2.44 M | 100.00% | 0.14% |
| BIRCHVIEW CAPITAL, LP | 11/14/2024 | 30,000 | $749,700 | 0.00% | 0.04% |
| BARCLAYS PLC | 11/19/2024 | 0 | $0 | -100.00% | 0.00% |
| ADIRONDACK TRUST CO | 10/08/2024 | 0 | $0 | -100.00% | 0.00% |
| CWM, LLC | 10/08/2024 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
Kiniksa Pharmaceuticals, Ltd.institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Kiniksa Pharmaceuticals, Ltd.. The most heavily invested institutionals were:
HARBOR CAPITAL ADVISORS, INC.: 97,543
Birchview Capital, LP: 30,000
ADIRONDACK TRUST CO: 0
ADVISOR GROUP HOLDINGS, INC.: 0
CWM, LLC: 0
BARCLAYS PLC: 0
0.18% of Kiniksa Pharmaceuticals, Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 5.86 M shares in the last 24 months. This purchase volume represents approximately $117.31 M in transactions.